Streetbeat News

Revenues

RCEL

AVITA Medical's stock is trading lower following the company's announcement of reduced revenue guidance for FY23, which is below market expectations.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 9:29 pm

PRST

Presto (PRST) forecasts its Q2 2024 total revenue to be between $4.8 million and $5 million, which is in line with the estimated $5 million.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 9:26 pm

PRST

Presto Automation reported a significant decrease in earnings and revenue for Q1 2024 compared to the same quarter last year. Earnings per share (EPS) dropped to $0.08 from $0.86, and revenue fell to $4.885 million from $7.779 million year-over-year (YoY).

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 9:25 pm

PRST

Presto Automation (NASDAQ:PRST) reported a decrease in Q1 sales to $4.88M, down 37.20% from $7.78M YoY, with earnings of $0.08 per share.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 9:24 pm

ZM

Zoom Video Communications Inc (NASDAQ:ZM) reported Q3 earnings with a 3.2% year-over-year increase in revenue to $1.14 billion, surpassing the consensus estimate of $1.12 billion. EPS was $1.29, beating estimates of $1.08 and marking the 18th consecutive beat. Enterprise customers grew by 5% to 219,700, with 3,731 contributing over $100,000 in revenue, up 13.5%. The company raised its full-year outlook for revenue, non-GAAP profitability, and free cash flow. Shares rose 6.09% after hours to $70.02.

Portfolio Pulse from Adam Eckert

November 20, 2023 | 9:23 pm

NHWK

NightHawk Biosciences reported a Q3 2023 revenue of $6.7 million, an increase from $5.98 million in the same quarter the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 9:22 pm

MYGN

Myriad Genetics, Inc. (NASDAQ:MYGN) has announced that its SneakPeek Early Gender DNA Test has delivered results to one million consumers. The test, which can determine fetal sex as early as six weeks into pregnancy with 99% accuracy, can be taken at home or in a clinic. Myriad Genetics acquired Gateway Genomics, the developer of SneakPeek, in 2022, enhancing its suite of reproductive health testing solutions. The company also celebrated one million patients screened with its Prequel Noninvasive Prenatal Screen earlier this year.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 9:19 pm

RCEL

AVITA Medical has revised its FY23 revenue guidance downwards from the previous range of $51M-$53M to a new range of $49.5M-$50.5M, which is below the estimated $52.03M.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 9:17 pm

TPCS

TechPrecision Corporation reported a decrease in earnings per share (EPS) to $(0.06) in Q2 2024 from $0.04 in the same quarter of the previous year. Revenue also declined to $7.970 million from $8.522 million year-over-year.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 9:11 pm

ZM

Zoom has reported a 13.5% year-over-year increase in the number of customers contributing more than $100,000 in trailing 12 months revenue.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 9:08 pm